Model
Edge
Lineage Cell Therapeutics
0001878732
Filing Type
4
Filing Date
11/25/2024
Updated
11/26/24, 2:55 PM
Filing
4
Earnings Release
Exhibits
4
Statement of Changes in Beneficial Ownership